Venous Thromboembolism (VTE)

The Core Measures data composite below show performance from January 2013 through June 2016. Data is shown by calendar year quarters.

Note: Changes made by CMS in January 2016 to the VTE measure is reflected from Q1 2016 numbers.

Data is preliminary for the most recent quarter and therefore subject to change.

Emory Healthcare’s FY16 YTD performance (July’15-June’16) for the Venous Thromboembolism (VTE) Composite is 95.9%.

EHC Venous Thromboembolism

Emory Healthcare’s Venous Thromboembolism Composite is the combined performance of Emory Johns Creek Hospital, Emory University Hospital, Emory University Hospital Midtown and Emory Saint Joseph’s Hospital of Atlanta.

Emory University Hospital’s FY16 YTD performance (July’15-June’16) for the Venous Thromboembolism (VTE) Composite is 96.7%.

EUH Venous Thromboembolism

Emory University Hospital Midtown’s FY16 YTD performance (July’15-June’16) for the Venous Thromboembolism (VTE) Compositeis 97.4%.

EUHM Venous Thromboembolism

Emory Johns Creek Hospital’s FY16 YTD performance (July’15-June’16) for the Venous Thromboembolism (VTE) Composite is 98.0%.

EJCH Venous Thromboembolism

Emory Saint Joseph’s Hospital FY16 YTD performance (July’15-June’16) for the Venous Thromboembolism (VTE) Composite is 95.9%.

ESJH Venous Thromboembolism